Načítá se...
lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1
Biguanides, including metformin (widely used in diabetes treatment) and phenformin, are AMP-activated protein kinase (AMPK) activators and potential drugs for cancer treatment. A more in-depth understanding of how cancer cells adapt to biguanide treatment may provide important therapeutic implicatio...
Uloženo v:
| Vydáno v: | Cell Cycle |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5224451/ https://ncbi.nlm.nih.gov/pubmed/27792451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2016.1249545 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|